# Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

> **NCT00702481** · PHASE2 · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 32 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Nimotuzumab
- **DRUG:** Cisplatin
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT00702481
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-28
- **Primary completion:** 2019-09-03
- **Final completion:** 2019-09-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702481, "Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00702481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*